LBP and serum lipopolysaccharide activity: Various clinical and preclinical studies [154,155] have documented a significant increase in IL-6 and lipopolysaccharide-binding protein (LBP) as well as gut barrier dysfunction resulting in the release of proinflammatory gut microbiota, giving rise to endotoxemia and a metabolic imbalance, a characteristic phenotype observed in cachectic models.